Your Location:
Home >
Browse articles >
Treatment of Diabetic Retinopathy with Blood Stasis, Collateral Obstruction, and Qi and Yin Deficiency Syndrome with Tongluo Mingmu Capsules: A Randomized, Double-blind, and Multi-center Phase Ⅲ Clinical Trial
Treatment of Diabetic Retinopathy with Blood Stasis, Collateral Obstruction, and Qi and Yin Deficiency Syndrome with Tongluo Mingmu Capsules: A Randomized, Double-blind, and Multi-center Phase Ⅲ Clinical Trial
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 7, Pages: 170-178(2024)
DOI: 10.13422/j.cnki.syfjx.20240895
Scan QR Code
Full Text(HTML)
Figs( 0 ) Tabs( 8 )
References
Publication Info
Metrics
496
Views
256
Downloads
1
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Clinical Efficacy of Rujietai Capsules in Treating 2 406 Cases of Breast Pain,Lumps and Other Symptoms of Breast Hyperplasia: A Multicenter,Real-world Clinical Study
Research Progress of Traditional Chinese Medicine in Improving Diabetic Retinopathy Based on Nrf2 Signaling Pathway
Discussion on Theory of "Gaozhuo" and Syndrome Differentiation and Treatment for Microcirculatory Disorders in Diabetic Retinopathy
Pinelliae Rhizoma and Its Prescription Compatibility for Depression Treatment: A Review
Astragali Radix Polysaccharides Promote M2 Polarization of OGD/R-induced BV2 Microglia by Inhibiting TLR4/NF-κB Signaling Pathway
Related Author
REN Junxia
WANG Yongzheng
LIU Xiaofei
SUN Li
YANG Libo
HAN Jianke
HAN Jianke
ZHANG Dongxiao
Related Institution
National Key Laboratory of Collaterals Theory Innovation and Transformation, Shijiazhuang Yiling Pharmaceutical Co.,Ltd.
High-level Key Discipline of Traditional Chinese Medicine(TCM) of National Administration of TCM Chinese Collaterals, Hebei Yiling Hospital
State Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang Yiling Pharmaceutical Co. Ltd.
Beijing Hospital of TCM,Capital Medical University
National Key Laboratory for Innovation and Transformation of Luobing Theory, Shijiazhuang Yiling Pharmaceutical Co. Ltd.


